Bandhan Healthcare Fund Direct Growth

Fund Overview

Fund Size

₹280 Cr

Expense Ratio

0.22%

ISIN

INF194KB1KF5

Minimum SIP

₹1,000

Exit Load

No Charges

Inception Date

28 Nov 2025

About this fund

Bandhan Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by Bandhan Mutual Fund. This fund has been in existence for 3 months and 6 days, having been launched on 28-Nov-25.
As of 05-Mar-26, it has a Net Asset Value (NAV) of ₹9.71, Assets Under Management (AUM) of 279.60 Crores, and an expense ratio of 0.22%.

Bandhan Healthcare Fund Direct Growth has given a CAGR return of -2.90% since inception.
The fund's asset allocation comprises around 95.38% in equities, 0.00% in debts, and 4.62% in cash & cash equivalents.
You can start investing in Bandhan Healthcare Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹1000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

Since Inception

-2.90%

— (Cat Avg.)

Portfolio Summaryas of 31st January 2026

Equity	₹266.69 Cr	95.38%
Others	₹12.91 Cr	4.62%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹23.93 Cr	8.56%
Apollo Hospitals Enterprise Ltd	Equity	₹22.97 Cr	8.22%
Divi's Laboratories Ltd	Equity	₹20.57 Cr	7.36%
Max Healthcare Institute Ltd Ordinary Shares	Equity	₹19.38 Cr	6.93%
Dr Reddy's Laboratories Ltd	Equity	₹18.88 Cr	6.75%
Cipla Ltd	Equity	₹16.81 Cr	6.01%
J.B. Chemicals & Pharmaceuticals Ltd	Equity	₹14.96 Cr	5.35%
Triparty Repo Trp_020226_val	Cash - Repurchase Agreement	₹14.86 Cr	5.32%
Mankind Pharma Ltd	Equity	₹11.04 Cr	3.95%
Lupin Ltd	Equity	₹9.69 Cr	3.46%
Ajanta Pharma Ltd	Equity	₹9.04 Cr	3.23%
Dr. Lal PathLabs Ltd	Equity	₹8.18 Cr	2.92%
Global Health Ltd	Equity	₹7.38 Cr	2.64%
Aurobindo Pharma Ltd	Equity	₹7.25 Cr	2.59%
Glenmark Pharmaceuticals Ltd	Equity	₹6.65 Cr	2.38%
Syngene International Ltd	Equity	₹6.15 Cr	2.20%
GlaxoSmithKline Pharmaceuticals Ltd	Equity	₹5.28 Cr	1.89%
Rainbow Childrens Medicare Ltd	Equity	₹5.12 Cr	1.83%
Sai Life Sciences Ltd	Equity	₹5.01 Cr	1.79%
Krishna Institute of Medical Sciences Ltd	Equity	₹4.83 Cr	1.73%
Abbott India Ltd	Equity	₹4.69 Cr	1.68%
Pfizer Ltd	Equity	₹4.56 Cr	1.63%
Sanofi India Ltd	Equity	₹4.02 Cr	1.44%
Star Health and Allied Insurance Co Ltd	Equity	₹3.75 Cr	1.34%
Shilpa Medicare Ltd	Equity	₹3.61 Cr	1.29%
Aster DM Healthcare Ltd Ordinary Shares	Equity	₹3.31 Cr	1.18%
Medi Assist Healthcare Services Ltd	Equity	₹3.19 Cr	1.14%
Jubilant Pharmova Ltd	Equity	₹2.95 Cr	1.05%
OneSource Specialty Pharma Ltd	Equity	₹2.69 Cr	0.96%
HealthCare Global Enterprises Ltd	Equity	₹2.45 Cr	0.88%
Concord Biotech Ltd	Equity	₹2.35 Cr	0.84%
Cohance Lifesciences Ltd	Equity	₹2.29 Cr	0.82%
Net Current Assets	Cash	₹-2.05 Cr	0.73%
Orchid Pharma Ltd	Equity	₹1.68 Cr	0.60%
Blue Jet Healthcare Ltd	Equity	₹1.25 Cr	0.45%
Inventurus Knowledge Solutions Ltd	Equity	₹0.78 Cr	0.28%
Cash Margin - Ccil	Cash - Repurchase Agreement	₹0.09 Cr	0.03%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹262.94 Cr	94.04%
Financial Services	₹3.75 Cr	1.34%

Risk & Performance Ratios

Fund Managers

Viraj Kulkarni

Since November 2025

Brijesh Shah

Since November 2025

Ritika Behera

Since November 2025

Gaurav Satra

Since November 2025

Additional Scheme Detailsas of 31st January 2026

ISIN

INF194KB1KF5

Expense Ratio

0.22%

Exit Load

No Charges

Fund Size

₹280 Cr

Age

3 months

Lumpsum Minimum

₹1,000

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Groww BSE Hospitals ETF Very High Risk	-	-	-	-
Mirae Asset Nifty 500 Healthcare ETF Very High Risk	-	-	-	-
Bandhan Healthcare Fund Direct Growth Very High Risk	0.2%	0.0%	₹279.60 Cr	-
Bandhan Healthcare Fund Regular Growth Very High Risk	1.0%	0.0%	₹279.60 Cr	-
Baroda BNP Paribas Health and Wellness Fund Direct Growth Very High Risk	0.6%	1.0%	₹544.81 Cr	-
Baroda BNP Paribas Health and Wellness Fund Regular Growth Very High Risk	2.3%	1.0%	₹544.81 Cr	-
Bajaj Finserv Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹307.34 Cr	8.0%
Bajaj Finserv Healthcare Fund Direct Growth Very High Risk	0.7%	1.0%	₹307.34 Cr	9.8%
PGIM India Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹88.38 Cr	14.8%
PGIM India Healthcare Fund Regular Growth Very High Risk	2.4%	0.0%	₹88.38 Cr	12.8%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹491.85 Cr	14.9%
WhiteOak Capital Pharma and Healthcare Fund Direct Growth Very High Risk	0.7%	1.0%	₹491.85 Cr	16.9%
DSP Nifty Healthcare ETF Regular Growth Very High Risk	0.2%	-	₹10.44 Cr	15.2%
Kotak Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹451.35 Cr	15.3%
Kotak Healthcare Fund Regular Growth Very High Risk	2.3%	0.0%	₹451.35 Cr	13.4%
HDFC Pharma and Healthcare Fund Regular Growth Very High Risk	2.1%	1.0%	₹1875.89 Cr	17.3%
HDFC Pharma and Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹1875.89 Cr	18.7%
Nippon India Pharma Fund Direct Growth Very High Risk	0.9%	1.0%	₹7875.40 Cr	11.3%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Regular Growth Very High Risk	1.9%	1.0%	₹6658.41 Cr	9.9%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Very High Risk	1.0%	1.0%	₹6658.41 Cr	10.8%
DSP Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹2971.07 Cr	3.7%
DSP Healthcare Fund Regular Growth Very High Risk	1.9%	0.0%	₹2971.07 Cr	2.3%
LIC MF Healthcare Fund Direct Growth Very High Risk	1.1%	1.0%	₹78.65 Cr	8.2%
LIC MF Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹78.65 Cr	6.8%
quant Healthcare Fund Direct Growth Very High Risk	0.8%	1.0%	₹340.56 Cr	10.2%
quant Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹340.56 Cr	8.4%
UTI Healthcare Fund Direct Growth Very High Risk	1.3%	1.0%	₹1055.01 Cr	11.7%
SBI Healthcare Opportunities Fund Direct Growth Very High Risk	0.9%	0.0%	₹3822.73 Cr	10.3%
Tata India Pharma & Healthcare Fund Regular Growth Very High Risk	2.1%	0.0%	₹1239.57 Cr	9.0%
Tata India Pharma & Healthcare Fund Direct Growth Very High Risk	0.7%	0.0%	₹1239.57 Cr	10.6%
ICICI Prudential Nifty Healthcare ETF Very High Risk	0.1%	-	₹135.28 Cr	15.3%
SBI Healthcare Opportunities Fund Regular Growth Very High Risk	1.9%	0.0%	₹3822.73 Cr	9.2%
Nippon India Pharma Fund Regular Growth Very High Risk	1.8%	1.0%	₹7875.40 Cr	10.3%
UTI Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹1055.01 Cr	10.6%
Axis NIFTY Healthcare ETF Very High Risk	0.3%	-	₹19.11 Cr	15.0%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹1007.47 Cr	14.9%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	1.9%	1.0%	₹2639.92 Cr	14.1%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹2639.92 Cr	15.7%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.4%	0.0%	₹210.46 Cr	4.3%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	0.5%	0.0%	₹210.46 Cr	6.3%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹49.65 Cr	15.2%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹812.03 Cr	10.7%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	1.0%	1.0%	₹812.03 Cr	12.1%
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.2%	-	₹40.21 Cr	11.6%

About the AMC

Bandhan Mutual Fund

022-66289999

https://bandhanmutual.com/

Total AUM

₹1,96,188 Cr

Address

6th Floor, 841, One World Center, Mumbai, 400013

Other Funds by Bandhan Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Bandhan Gold ETF FOF Direct Growth High Risk	0.1%	0.0%	₹96.00 Cr	-
Bandhan Silver ETF FOF Direct Growth Very High Risk	0.1%	0.0%	₹132.07 Cr	-
Arudha Hybrid Long-Short Fund Direct Growth Low to Moderate Risk	-	0.0%	₹38.41 Cr	-
Bandhan Healthcare Fund Direct Growth Very High Risk	0.2%	0.0%	₹279.60 Cr	-
Bandhan BSE India Sector Leaders Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹26.67 Cr	-
Bandhan Multi-Factor Fund Direct Growth Very High Risk	0.7%	0.0%	₹623.68 Cr	-
Bandhan CRISIL-IBX Financial Services 3-6 Months Debt Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹381.24 Cr	-
Bandhan CRISIL-IBX 10:90 Gilt + SDL Index - Dec 2029 Fund Direct Growth Moderate Risk	0.0%	0.0%	₹0.38 Cr	-
Bandhan Nifty Next 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹25.16 Cr	14.4%
Bandhan Fixed Maturity Plan (FMP) - Series 209 (93 Days) Direct Growth Low to Moderate Risk	-	0.0%	-	-
Bandhan Nifty Alpha Low Volatility 30 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹8.75 Cr	10.8%
Bandhan Nifty 200 Quality 30 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹12.12 Cr	8.7%
Bandhan Nifty 500 Momentum 50 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹28.41 Cr	10.6%
Bandhan Nifty 500 Value 50 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹23.75 Cr	31.6%
Bandhan Business Cycle Fund Direct Growth Very High Risk	0.6%	0.0%	₹1341.75 Cr	9.9%
Bandhan Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹30.85 Cr	16.8%
Bandhan BSE Healthcare Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹15.72 Cr	11.5%
Bandhan Nifty Bank Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹20.85 Cr	22.4%
Bandhan Nifty Total Market Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹39.46 Cr	12.2%
Bandhan Innovation Fund Direct Growth Very High Risk	0.6%	0.0%	₹1913.04 Cr	18.2%
Bandhan Long Duration Fund Direct Growth Moderate Risk	0.3%	0.0%	₹119.71 Cr	3.9%
Bandhan Multi Asset Allocation Fund Direct Growth Very High Risk	0.4%	0.0%	₹2966.55 Cr	26.0%
Bandhan Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹58.18 Cr	8.1%
Bandhan Nifty Alpha 50 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹497.81 Cr	12.6%
Bandhan Retirement Fund Direct Growth Moderately High risk	0.7%	0.0%	₹183.96 Cr	9.9%
Bandhan Nifty IT Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹31.61 Cr	-19.4%
Bandhan Interval Fund - Series 17 Direct Growth Moderate Risk	-	0.0%	-	-
Bandhan Fixed Term Plan Series 197 Direct Growth Moderate Risk	-	0.0%	-	-
Bandhan Fixed Term Plan Series 179 Direct Growth Low to Moderate Risk	-	0.0%	₹334.47 Cr	8.0%
Bandhan Overnight Fund Direct Growth Low Risk	0.1%	0.0%	₹843.50 Cr	5.6%
Bandhan Liquid Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹15367.16 Cr	6.3%
Bandhan Core Equity Fund Direct Growth Very High Risk	0.5%	1.0%	₹13968.37 Cr	16.6%
Bandhan Dynamic Bond Fund Direct Growth Low to Moderate Risk	0.7%	0.0%	₹2274.86 Cr	5.0%
Bandhan Large Cap Fund Direct Growth Very High Risk	0.9%	0.0%	₹1979.87 Cr	15.4%
Bandhan Asset Allocation FOF Aggressive Plan Direct Growth Very High Risk	0.1%	1.0%	₹18.66 Cr	13.4%
Bandhan Government Securities Fund Investment Plan Direct Growth Low to Moderate Risk	0.5%	0.0%	₹1999.03 Cr	5.2%
Bandhan Focused Equity Fund Direct Growth Very High Risk	0.8%	1.0%	₹1993.81 Cr	11.8%
Bandhan Government Securities Fund - Constant Maturity Plan Direct Growth Moderate Risk	0.3%	0.0%	₹337.85 Cr	7.9%
Bandhan Infrastructure Fund Direct Growth Very High Risk	0.9%	0.0%	₹1428.17 Cr	9.4%
Bandhan Regular Savings Fund Direct Growth Moderately High risk	1.0%	0.0%	₹98.99 Cr	7.8%
Bandhan Bond Fund - Medium Term Plan Direct Growth Low to Moderate Risk	0.7%	0.0%	₹1375.47 Cr	6.8%
Bandhan Bond Fund - Income Plan Direct Growth Moderate Risk	1.3%	1.0%	₹473.11 Cr	4.8%
Bandhan Money Manager Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹15693.51 Cr	7.3%
Bandhan Bond Fund - Short Term Plan Direct Growth Low to Moderate Risk	0.3%	0.0%	₹10155.00 Cr	7.5%
Bandhan Nifty 50 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹2231.70 Cr	12.0%
Bandhan Sterling Value Fund Direct Growth Very High Risk	0.7%	1.0%	₹10103.58 Cr	11.0%
Bandhan Flexi Cap Fund Direct Growth Very High Risk	1.1%	1.0%	₹7477.59 Cr	13.2%
Bandhan Crisil IBX Gilt November 2026 Index Fund Direct Growth Moderate Risk	0.1%	0.0%	₹99.62 Cr	7.3%
Bandhan Tax Advantage (ELSS) Fund Direct Growth Very High Risk	0.7%	0.0%	₹7059.87 Cr	13.3%
Bandhan Low Duration Fund Direct Growth Low to Moderate Risk	0.3%	0.0%	₹5927.39 Cr	7.1%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of Bandhan Healthcare Fund Direct Growth?

The NAV of Bandhan Healthcare Fund Direct Growth, as of 05-Mar-2026, is ₹9.71.

What is the portfolio composition of Bandhan Healthcare Fund Direct Growth?

The fund's allocation of assets is distributed as 95.38% in equities, 0.00% in bonds, and 4.62% in cash and cash equivalents.

Who manages the Bandhan Healthcare Fund Direct Growth?

The fund managers responsible for Bandhan Healthcare Fund Direct Growth are:-

Viraj Kulkarni
Brijesh Shah
Ritika Behera
Gaurav Satra

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

Bandhan Healthcare Fund Direct Growth

Fund Overview